MediWound Ltd. (MDWD) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
MediWound (MDWD) Q1 2026: BARDA Contract Adds $197M Visibility as Enrollment Pace Delays Phase III Milestone
May 27, 2026
-
MediWound (MDWD) Q4 2025: Manufacturing Capacity Grows 6x, Setting Stage for Revenue Acceleration
March 05, 2026
-
MediWound (MDWD) Q3 2025: NexoBridge Demand Drives 38% U.S. Growth, Manufacturing Expansion Sets Stage for Global Upside
November 20, 2025
-
MediWound (MDWD) Q2 2025: NexoBrid US Sales Jump 52% as Manufacturing Scale-Up Nears Completion
August 14, 2025